- Press Release Distribution

Ancient DNA reveals the appearance of a 6th century Chinese emperor

Ancient DNA reveals the appearance of a 6th century Chinese emperor
( What did an ancient Chinese emperor from 1,500 years ago look like? A team of researchers reconstructed the face of Chinese Emperor Wu of Northern Zhou using DNA extracted from his remains. The study, published March 28 in the journal Current Biology, suggests the emperor’s death at the age of 36 might be linked to a stroke. It also sheds light on the origin and migration patterns of a nomadic empire that once ruled parts of northeastern Asia.

Emperor Wu was a ruler of the Northern Zhou dynasty in ancient China. Under his reign from AD 560 to AD 578, Emperor Wu built a strong military and unified the northern part of ancient China after defeating the Northern Qi dynasty.

Emperor Wu was ethnically Xianbei, an ancient nomadic group that lived in what is today Mongolia and northern and northeastern China.

“Some scholars said the Xianbei had ‘exotic’ looks, such as thick beard, high nose bridge, and yellow hair,” says Shaoqing Wen, one of the paper’s corresponding authors at Fudan University in Shanghai. “Our analysis shows Emperor Wu had typical East or Northeast Asian facial characteristics,” he adds.

In 1996, archaeologists discovered Emperor Wu’s tomb in northwestern China, where they found his bones, including a nearly complete skull. With the development of ancient DNA research in recent years, Wen and his team managed to recover over 1 million single-nucleotide polymorphisms (SNPs) on his DNA, some of which contained information about the color of Emperor Wu’s skin and hair. Combined with Emperor Wu’s skull, the team reconstructed his face in 3D. The result shows Emperor Wu had brown eyes, black hair, and dark to intermediate skin, and his facial features were similar to those of present-day Northern and Eastern Asians.

“Our work brought historical figures to life,” says Pianpian Wei, the paper’s co-corresponding author at Fudan University. “Previously, people had to rely on historical records or murals to picture what ancient people looked like. We are able to reveal the appearance of the Xianbei people directly.”

Emperor Wu died at the age of 36, and his son also died at a young age with no clear reason. Some archaeologists say Emperor Wu died of illness, while others argue the emperor was poisoned by his rivals. By analyzing Emperor Wu’s DNA, researchers found that the emperor was at an increased risk for stroke, which might have contributed to his death. The finding aligns with historical records that described the emperor as having aphasia, drooping eyelids, and an abnormal gait—potential symptoms of a stroke.

The genetic analysis shows the Xianbei people intermarried with ethnically Han Chinese when they migrated southward into northern China. “This is an important piece of information for understanding how ancient people spread in Eurasia and how they integrated with local people,” Wen says.

Next, the team plans to study the people who lived in ancient Chang’an city in northwestern China by studying their ancient DNA. Chang’an was the capital city of many Chinese empires over thousands of years and the eastern terminus of the Silk Road, an important Eurasian trade network from the second century BC until the 15th century. The researchers hope that the DNA analysis can reveal more information about how people migrated and exchanged cultures in ancient China.


Funding information for this paper can be found in the paper text. The authors declare no competing interests.

Current Biology, Du et al. “Ancient genome of the Chinese emperor Wu of Northern Zhou”

Current Biology (@CurrentBiology), published by Cell Press, is a bimonthly journal that features papers across all areas of biology. Current Biology strives to foster communication across fields of biology, both by publishing important findings of general interest and through highly accessible front matter for non-specialists. Visit To receive Cell Press media alerts, contact


[Attachments] See images for this press release:
Ancient DNA reveals the appearance of a 6th century Chinese emperor


DNA study IDs descendants of George Washington from unmarked remains, findings to aid service member IDs going back to World War II

New DNA sequencing technologies have identified the historical remains of George Washington’s grandnephews, Samuel Walter Washington and George Steptoe Washington Jr., and their mother, Lucy Payne Washington, from unmarked, fragmentary bones left at the Harewood family cemetery in Charles Town, West Virginia, in the mid-1800s. In addition to enabling the remains in question to be reunited and reburied if desired, the researchers plan to apply the validated DNA analysis techniques to their ongoing efforts to identify the remains of service members lost around the world in past conflicts going back to World War II. The findings appear March 28 in the journal iScience. “The ...

Familial Alzheimer’s disease transferred via bone marrow transplant in mice

Familial Alzheimer’s disease transferred via bone marrow transplant in mice
Familial Alzheimer’s disease can be transferred via bone marrow transplant, researchers show March 28 in the journal Stem Cell Reports. When the team transplanted bone marrow stem cells from mice carrying a hereditary version of Alzheimer’s disease into normal lab mice, the recipients developed Alzheimer’s disease—and at an accelerated rate. The study highlights the role of amyloid that originates outside of the brain in the development of Alzheimer’s disease, which changes the paradigm of Alzheimer’s from being a disease ...

Perspectives of oncologists on the ethical implications of using AI for cancer care

About The Study: In this survey study of 204 oncologists, few reported that patients needed to understand artificial intelligence (AI) models, but most agreed that patients should consent to their use, and many tasked patients with choosing between physician- and AI-recommended treatment regimens. These findings suggest that the implementation of AI in oncology must include rigorous assessments of its effect on care decisions as well as decisional responsibility when problems related to AI use arise.  Authors: Gregory A. Abel, M.D., M.P.H., of the Dana-Farber Cancer Institute in Boston, is the corresponding author.   To ...

Industry payments to US physicians by specialty and product type

About The Study: From 2013 to 2022, U.S. physicians received $12.1 billion from industry. More than half of physicians received at least one payment. Payments varied widely between specialties and between physicians within the same specialty. A small number of physicians received the largest amounts, often exceeding $1 million, while the median physician received much less, typically less than a hundred dollars.   Authors: Andrew J. Foy, M.D., of the Penn State Milton S. Hershey ...

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

BOSTON --  Andrew E. Place, MD, PhD, has been named as Vice President, Pediatric Chief Medical Officer (CMO) at Dana-Farber Cancer Institute (within the Department of Pediatric Oncology) and Boston Children’s Hospital (within the Division of Hematology/Oncology) for the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.  In this role, Place will work closely with institutional and departmental leaders at Boston Children’s Hospital (BCH) and Dana-Farber to help define and implement clinical strategies and operational approaches that enhance smooth and efficient running of clinical care ...

COVID-19 antibody discovery could explain long COVID

COVID-19 antibody discovery could explain long COVID
UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the difficult acute effects of COVID-19, long COVID and possibly other viruses. Researchers led by UVA’s Steven L. Zeichner, MD, PhD, found that COVID-19 may prompt some people’s bodies to make antibodies that act like enzymes that the body naturally uses to regulate important functions – blood pressure, for example. Related enzymes also regulate ...

Wild plants face viral surprise

Wild plants face viral surprise
Just as many people battle seasonal colds and flu, native plants face their own viral threats. People have long known that plants can succumb to viruses just like humans. Now, a new study led by Michigan State University and the University of California, Riverside reveals a previously unknown threat: non-native crop viruses are infecting and jeopardizing the health of wild desert plants. “For years, the ecological field assumed wild plants were immune to invasive viruses that damage crops,” said Carolyn ...

Storing electrons from hydrogen for clean chemical reactions

Storing electrons from hydrogen for clean chemical reactions
Fukuoka, Japan—Researchers from Kyushu University have developed a hydrogen energy carrier to address some of the biggest hurdles in the path towards a sustainable hydrogen economy. As explained in a paper published in JACS Au, this novel compound can efficiently “store electrons” from hydrogen in a solid state to use in chemical reactions later. Hydrogen is a promising source of clean energy with a lot of untapped potential applications in industry and everyday life. Unlike conventional fuels, hydrogen can be used to generate electricity without producing greenhouse ...

Unlocking how to use mRNA to target Alzheimer’s disease

Unlocking how to use mRNA to target Alzheimer’s disease
Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias.  To date, mRNA has been predominantly used for vaccines, including those used to fight COVID-19.  New research published today in Brain Communications establishes The Florey as a key player in the mRNA field, with Dr Rebecca Nisbet taking the technology in a new direction.  “This is the first time mRNA has been explored for use in Alzheimer’s disease,” Dr Nisbet said. “Our work in cell models demonstrates that this technology ...

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research
East Hanover, NJ – March 28, 2024 – Kessler Foundation received two grants from The New Jersey Commission on Spinal Cord Research that will fuel innovative research in the field of spinal cord injury (SCI). These grants will fund efforts aimed at improving the cognitive assessment of individuals with traumatic SCI and pilot-testing the first-of-its-kind Spinal Cord Injury Personal Assistance Services Survey (SCI-PASS). Traumatic spinal cord injury (tSCI) often leads to cognitive impairment, affecting up to 60 percent of individuals living with this condition. “The challenge lies in assessing cognitive functions in people with tSCI, as many existing tests rely on upper limb ...


Lab-grown muscles reveal mysteries of rare muscle diseases

Primary hepatic angiosarcoma: Treatment options for a rare tumor

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia

Navigating the Pyrocene: Recent Cell Press papers on managing fire risk

Restoring the Great Salt Lake would have environmental justice as well as ecological benefits

Cannabis, tobacco use, and COVID-19 outcomes

A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes

Scientists document self-propelling oxygen decline in the oceans

Activating molecular target reverses multiple hallmarks of aging

Cannabis use tied to increased risk of severe COVID-19

How to make ageing a ‘fairer game’ for all wormkind

Supporting the right small changes can have big impacts

Grafted cucumbers get a boost: pumpkin's secret to withstanding salinity

Unlocking broccoli's genome: key to enhanced health benefits

New insights into methyl jasmonate-induced saponin biosynthesis in balloon flower

Unraveling the role of ADGRF5: Insights into kidney health and function

JMIR Dermatology accepted for MEDLINE indexing

Reduced infections seen in CLL and NHL patients undergoing immunoglobulin testing and replacement therapy

Human activity: A double-edged sword in the face of drought

Portfolio performance in financial management: apraize, analyze, act.

Landmark Nature Medicine study reports promising new treatment reduces suffering in Sanfilippo syndrome

Membrane protein analogues could accelerate drug discovery

Berkeley Lab researchers advance AI-driven plant root analysis

Cleveland Clinic study shows weight loss surgery cuts risk of heart complications and death in patients with obstructive sleep apnea and obesity

SQUID pries open AI black box

Resiliency shaped by activity in the gut microbiome and brain

Inspired by nature: synthetic nightshade molecule effective against leukemia cells

Promise green hydrogen may not always be fulfilled

Unifying behavioral analysis through animal foundation models

Up to 30 percent more time: Climate change makes it harder for women to collect water

[] Ancient DNA reveals the appearance of a 6th century Chinese emperor